Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
- Status
- TERMINATED
- Phase
- PHASE2
The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.
- Status
- COMPLETED
- Phase
- PHASE1
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
- Status
- TERMINATED
- Phase
- PHASE2
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of MAS825 in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm
- Status
- COMPLETED
- Phase
- PHASE3
Managed Access Programs for ABL001, Asciminib
- Status
- AVAILABLE
- Phase
- N/A
Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease
- Status
- COMPLETED
- Phase
- PHASE3
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Lamprene Multiple Patient Program
- Status
- AVAILABLE
- Phase
- N/A
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations
- Status
- TERMINATED
- Phase
- PHASE2